Synthesis and studies on antidepressant activity of 2′,4′, 6′-trihydroxychalcone derivatives

Medicinal Chemistry Research

Volumn 21, Issue 7, 2012, Pages 1290-1296

  Sui, Xin ^a,b   Quan, Ying Chun ^b   Chang, Yue ^b   Zhang, Rui Peng ^b   Xu, Yin Feng ^a   Guan, Li Ping ^a  

^a ZHEJIANG OCEAN UNIVERSITY   (China)

^b YANBIAN UNIVERSITY   (China)

Author keywords

2 ,4 ,6 trihydroxychalcone derivatives; Antidepressant activity; Synthesis

Indexed keywords

2 BROMO 2',4',6' TRIHYDROXYCHALCONE; 2 CHLORO 2',4',6' TRIHYDROXYCHALCONE; 2 FLUORO 2',4',6' TRIHYDROXYCHALCONE; 2',4',6' TRIHYDROXYCHALCONE DERIVATIVE; 2,4 DICHLORO 2',4',6' TRIHYDROXYCHALCONE; 3 BROMO 2',4',6' TRIHYDROXYCHALCONE; 3 CHLORO 2',4',6' TRIHYDROXYCHALCONE; 3 FLUORO 2',4',6' TRIHYDROXYCHALCONE; 3 METHOXY 4,2',4',6' TETRAHYDROXYCHALCONE; 3,4 DIMETHOXY 2',4',6' TRIHYDROXYCHALCONE; 3,4 METHYL 2',4',6' TRIHYDROXYCHALCONE; 3,4,2',4',6' PENTAHYDROXYCHALCONE; 4 BROMO 2',4',6' TRIHYDROXYCHALCONE; 4 CHLORO 2',4',6' TRIHYDROXYCHALCONE; 4 FLUORO 2',4',6' TRIHYDROXYCHALCONE; 4 METHOXYL 2',4',6' TRIHYDROXYCHALCONE; 4 METHYL 2',4',6' TRIHYDROXYCHALCONE; ANTIDEPRESSANT AGENT; CHALCONE DERIVATIVE; FLUOXETINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; EXPERIMENTAL TEST; FORCED SWIMMING TEST; IMMOBILIZATION; INFRARED SPECTROSCOPY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TAIL SUSPENSION TEST;

EID: 85027916648     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9640-2     Document Type: Article

References (23)

1. Bekhit AA, Habib NS, Din A, Bekhit A (2001) Synthesis and antimicrobial evaluation of chalcone and syndrome derivatives of 4(3H)-quinazolinone. Boll Chim Farm 140:297-301
2. Borsini F, Voltera G, Meli A (1986) Dose the behavioral 'despair' test measure 'despair'. Physiol Behav 38:385-389
3. Butterweck V, Jürgenliemk G, Nahrstedt A, Winterhoff H (2000) Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med 66:3-6
4. Charney DS, Crothe DR, Smith SL, Brady KT, Kaltsounis-Pucktt J, Wright CW, Lsitd LK, Rush AJ (2002) Overview of psychiatric disorder and the role of newer antidepressants. J Clin Psychiatry 63:3-9
5. Cryan JF, Markou A, Luck L (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-245
6. Husan SR, Cliard J, Cillard P (1987) Hydroxyl radical scavenging activity of flavoids. Phytochemistry 26:2487-2491
7. Lopez SN, Castelli MV, Zacchino SA, Dominguez JC, Lobo G, Chrris-Charriss J, Cortes JC, Ribas JC, Devia C, Rodriguez AM, Enrizz RD (2001) In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorg Med Chem 9:1999-2013
8. Murray CJL, Lopez AD (1996) The global burden of disease. Harvard Univ Press, Cambridge, p 21
9. Nakazawa T, Yasuda T, Ueda J, Ohsawa K (2003) Antidepressantlike effects of apigenin and 2,4,5-trimethoxycinnamic acid from Perilla frutescents in the forced swimming test. Biol Pharm Bull 26:474-480
10. Nishida J, Kawabata J (2006) DPPH radical scavenging reaction of hydroxy- and methoxychalcones. Biosci Biotechnol Biochem 70:193-202
11. Nishida J, Gao H, Kawabata J (2007) Synthesis and evaluation of 2′,4′,6′-trihydroxychalcones as a new class of tyrosinase inhibitors. Bioorg Med Chem 15:2396-2402
12. Porsolt RD (1981) In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: neurochemical behavioral and clinical perspectives. Raven Press, New York, pp 129-139
13. Porsolt RD, Bertin A, Jalfre M (1977) Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-336
14. Raiendra Prasad Y, Lakshmana Rao A, Prasoona L, Murali K, Ravi Kumar P (2005) Synthesis and antidepressant activity of some 1,3,5-triphenyl-2- pyrazolines and 3-(200-hydroxynaphthal-en-100-yl)-1,5-diphenyl-2-pyrazolines. Bioorg Med Chem Lett 15: 5030-5034
15. Rybnikova E, Mironova V, Pivina S, Tulkova E, Ordyan N, Vataeva L, Vershinina E, Abritalin E, Kolchev A, Nalivaeva N, Tumer AJ, Samoilov M (2007) Antidepressant-like effects of mild hypoxia preconditioning in the learned helplessness model in rats. Neurosci Lett 417:234-239
16. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367-370
17. Viana GS, Bandeira MA, Matos FJ (2003) Analgesic and antiinflammatory effects of chalcones isolated from Myracrodruon urundeuva allemal. Phytomedicine 10:189-196
18. Wang WX, Hu XY, Liu H, Guo HZ, Guo D (2007) A studies on antidepressant activity of ten natural flavonoid compounds of hyperin. Chin Tradit Herb Drugs 38:900-902
19. Willner P (1991) Animal models as stimulations of depression. Trends Pharmacol Sci 12:131-138
20. Willner P, Mitchell PJ (2002) The validity of animal models of predisposition to depression. Behav Pharmacol 13:169-188
21. Wu JH, Wang XH, Yi YH, Lee KL (2003) Anti-AIDS agents 54, a potent anti-HIV chalcone and flavonoids from genus desmos. Bioorg Med Chem Lett 13:1813-1815
22. Yi LT, Li JM, Li YC, Pan Y, Xu Q, Kong LD (2008) Antidepressantlike behavioral and neurochemical effects of the citrus-associated chemical apigenin. Life Sci 82:741-751
23. Zhao LM, Jin HS, Sun LP, Piao HR, Quan ZS (2005) Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. Bioorg Med Chem Lett 15:5027-5029